Faruqi & Faruqi LLP

Recent News

MREO SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Mereo Investors Who Suffered Losses Exceeding $50,000 To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Mereo between June 5, 2023 and December 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New

2026-02-08 1:26 PM EST

SDM SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Smart Digital (SDM) Investors of the Securities Class Action Lawsuit Deadline on March 16, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Smart Digital Investors Who Suffered Losses Exceeding $50,000 To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Smart Digital between May 5, 2025 and September 26, 2025 at 9:34 AM EST and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional informati

2026-02-08 1:12 PM EST

METC SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Ramaco (METC) Investors of Securities Class Action Deadline on March 31, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Ramaco Investors Who Suffered Losses Exceeding $50,000 To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Ramaco between July 31, 2025 and October 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, N

2026-02-08 1:10 PM EST

BRBR SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds BellRing (BRBR) Investors of the Securities Class Action Lawsuit Deadline on March 23, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages BellRing Investors Who Suffered Losses Exceeding $50,000 To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in BellRing between November 19, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New Y

2026-02-08 1:58 AM EST

FRMI INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Fermi (FRMI) Investors of Securities Class Action Deadline on March 6, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Fermi To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired securities in Fermi (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's October 2025 initial public offering ("IPO" or the "Offering"); and/or (b) securities between...

2026-02-07 10:08 AM EST

AGL INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in agilon health to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in agilon health between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York,

2026-02-07 9:56 AM EST

BYND INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Beyond Meat (BYND) Investors of Securities Class Action Deadline on March 24, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Beyond Meat to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Beyond Meat between February 27, 2025 and November 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, N

2026-02-07 9:35 AM EST

PLUG INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Plug Power (PLUG) Investors of Securities Class Action Deadline on April 3, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Plug Power To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Plug Power between January 17, 2025 and November 13, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New Yor

2026-02-07 8:56 AM EST

PMI INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 3, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Picard Medical to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Picard Medical between September 2, 2025 and October 31, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New Yo

2026-02-07 8:23 AM EST

SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses in Aquestive Therapeutics to Contact Him Directly to Discuss Their Options If you suffered significant losses in Aquestive Therapeutics stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New

2026-02-05 6:50 PM EST

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bath and Body Works

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Bath & Body Works to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Bath & Body Works between June 4, 2024 and November 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]

2026-02-05 5:24 PM EST

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BellRing Brands

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in BellRing to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in BellRing between November 19, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--

2026-02-05 5:18 PM EST

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us